April 23, 2024
The original article was provided by Greiner.
For over three decades, Greiner Bio-One has been a trusted manufacturer of microplates for diagnostics and immunological research, offering unrivalled quality and compatibility with automated systems.
The cornerstone of ELISA assays lies in the binding of assay components to the solid surface of the microplate. Greiner Bio-One's ELISA microplates are crafted from high-quality virgin polystyrene, ensuring optimal performance. Whether you're conducting colorimetric, luminescence, or fluorescence measurements, microplates are available in clear, black, and white variants to suit your specific needs.
The commitment to quality extends beyond manufacturing. Each batch undergoes rigorous quality control in their assurance laboratory, ensuring consistent and reliable results for your research and diagnostic applications.
Key Features:
Additional Product Information:
ELISA assays offer rapid, sensitive, and cost-effective detection and quantification of analytes such as peptides, proteins, antibodies, and hormones. 96-well Immunology and ELISA plates are designed to maintain high standards of consistency and reproducibility, catering to a wide range of applications.
Choose from High-Binding 96-Well Plates, featuring a hydrophilic surface for increased protein binding, or Medium-Binding 96-Well Plates, ideal for non-polar proteins and peptides. Whether you're conducting direct, indirect, sandwich, or competitive ELISA assays, microplates provide the solid foundation you need for accurate and efficient analysis.
Experience unparalleled performance and reliability with Greiner Bio-One's 96-well ELISA microplates.
【Find Greiner Microplates HERE to to safeguard your samples.】
April 23, 2024
The original article was provided by Greiner.
In the quest for efficient cell filtration solutions, Greiner Bio-One introduces EASYstrainer cell strainers, revolutionizing the process of filtering cell suspensions. Whether it's isolating primary cells after enzymatic tissue digestion or preparing cells for flow cytometry, EASYstrainer offers a seamless experience.
The versatility of EASYstrainer is evident in its compatibility with various tube sizes and mesh options. The large EASYstrainer fits all conical 50 ml tubes, available with mesh sizes of 40, 70, and 100 μm. Meanwhile, the EASYstrainer Small caters to 15 ml tubes and smaller vessels, with mesh sizes ranging from 20 to 100 μm.
One of the standout features of EASYstrainer is its ability to streamline aseptic work. The stackability of different mesh sizes allows for simultaneous separation of cells based on size. Moreover, the innovative design of the EASYstrainer Small enables the inversion of the upper part, facilitating the rinsing out of retained cells for further use. With convenient handle and surrounding rim options, users can maintain aseptic conditions and avoid accidental contact with sterile filter material.
EASYstrainer offers several key advantages:
Unlock the full potential of your cell filtration processes with EASYstrainer. Experience seamless compatibility with 15 & 50 ml PP tubes, maximizing synergies across your laboratory workflows.
【Find Greiner EASYstrainer HERE to facilitate you Lab.】
April 19, 2024
Interpath Services, as part of the Bunzl group, is a member of several international organisations that seek to monitor and improve supply chain transparency.
Supply chain transparency is all about communicating the environmental, social and ethical aspects of a company’s sourcing methods. This consists of information about products and how they were made, including working conditions, environmental practices and business ethics.
Providing this information is important as consumers are becoming increasingly more aware of sustainable and ethical practice in business. According to researchers at the MIT Sloan School of Management, consumers are willing to pay up to 10% more for products from companies that provide greater supply chain transparency. This is why Bunzl group is a member of recognised supplier data exchange organisations like EcoVadis and Sedex.
Felicity Kelly, Bunzl group’s Head of Sustainability, explains that, “Aligning with organisations like these ensures we operate with the highest transparency standards, and allows our customers to easily access supply chain information.”
EcoVadis is one of the world’s largest provider of sustainability ratings. Their work helps businesses to reduce risk, drive performance and improve environmental and social outcomes. Bunzl group submitted their policies and documented processes to EcoVadis for review and were awarded in recognition of their sustainability achievement.
Similarly, Sedex is the world’s leading ethical trade membership organisation. As a seller member of Sedex, Bunzl group provides information on labour standards, health and safety, and environment and business ethics. All four pillars account for relevant legal requirements, international standards and good practice. Through these partnerships, Bunzl group will continually work to improve responsible business practices while also seeking to build a sustainable network.
April 19, 2024
At Interpath Services, excellence isn't just a goal; it's a standard upheld by our dedicated team of specialists. We take pride in our purpose-led approach, setting us apart from competitors. Today, we're thrilled to introduce you to Chris Simitzis, our Southern Region Sales Manager, whose journey with Interpath began on September 21st, 2007.
Q. What is your career background that makes you so suited to being an Interpath specialist?
A. "I always had a passion for science, leading me to pursue a Bachelor of Science Degree at Deakin University. My path then led me to the Private Pathology sector, where I worked as a Medical Scientist for 7 years. Transitioning into a Sales role with Interpath was a natural progression that aligned with my passion for both science and customer interaction."
Q. Tell us about your role with Interpath? What is your area of expertise?
A. "As the Southern Region Sales Manager, I oversee Victoria, Tasmania, South Australia, Western Australia, and Northern Territory. My role involves collaborating closely with Account Managers to ensure optimal customer experiences and outcomes. I'm deeply engaged with Interpath's Brand Partners, facilitating discussions on new products, trends, and challenges. Additionally, I handle Tender responsibilities for the region."
Q. What most do you like about your role and why?
A. "Having been with Interpath for over 16 years, I've had the privilege of gaining insight into various facets of the business. What I cherish most is the opportunity to work closely with customers, ensuring mutual success. Building relationships with both existing and new customers and witnessing the impact of Interpath's value proposition is incredibly rewarding."
Q. When you started with Interpath what most surprised you?
A. "Despite the evolving landscape over the years, one constant has been the unwavering respect and partnership from our customers. Interpath's reputation remains robust, reflecting our commitment to excellence and customer-centric approach."
Q. What are some of the challenges the market is facing?
A. "In 2024, we've encountered challenges stemming from the security situation in the Red Sea, impacting freight transit through the Suez Canal. Despite these obstacles, Interpath remains steadfast in ensuring consistent supply to our customers."
Q. What are your main priorities for 2024?
A. "My main priorities revolve around providing unwavering support to my sales team, enabling them to achieve their objectives seamlessly. Additionally, fostering collaborative partnerships with customers through training and technical support remains paramount."
Q. What do you expect the big industry trends to be of 2024?
A. "A notable trend we've observed is the increasing demand for long-term fixed price contracts, driven by global instability. Customers across sectors seek stability amidst uncertainty, prompting a surge in fixed pricing contracts."
Q. What’s the biggest challenge facing the customers in the industry?
A. "Continuity of supply remains a significant challenge, exacerbated by the aftermath of the Covid pandemic. Interpath continuously adapts and enhances internal processes to mitigate potential disruptions, ensuring seamless service delivery."
Q. What’s the biggest lesson you’ve learned over the past 12-18 months?
A. "The enduring loyalty of our customers has been a profound lesson. Despite supply shortages during Covid, customers' unwavering commitment to quality reaffirmed our dedication to delivering excellence."
Q. Is there a message you’d like to share with your customers?
A. "To our valued customers, thank you for your steadfast support and loyalty. Interpath remains committed to providing exceptional service and tailored solutions, navigating global challenges alongside you. Here's to a successful 2024 and beyond!"
At Interpath, our commitment to excellence and customer-centricity drives everything we do. Stay tuned as we continue to spotlight our exceptional team members, shaping the future of healthcare solutions.
If you would like to contact Chris or one of the Interpath team, please do so HERE.
March 26, 2024
The original article was provided by SSIbio (Scientific Specialties).
Centrifuge Tubes stand as the trusted choice in laboratories worldwide, catering to a wide range of applications from 0.5 mL to 5 mL. Crafted from a proprietary, ultra-pure resin, these tubes ensure optimal clarity, purity, and strength, backed by over two decades of research and innovation. Let's delve into the advantages and features of Scientific Specialties Microcentrifuge Tubes:
Advantages of Scientific Specialties Microcentrifuge Tubes:
- Ultra-Pure Material: Constructed from virgin polypropylene, Scientific Specialties tubes deliver crystal clarity, enhancing sample visibility.
- High-Contrast Graduations: Clear graduations at every 100 µL facilitate accurate volume estimation, ensuring precise measurements.
- Sample Recovery: Certain styles feature NoStick® resin technology, maximizing sample recovery and minimizing sample loss.
- Easy-to-Use Cap Design: The cap design ensures a simple yet secure seal, facilitating easy opening and closing.
0.5, 1.5, and 2 mL Microcentrifuge Tubes:
5 mL Microcentrifuge Tubes:
Order Scientific Specialties Centrifuge Tubes & Other Tubes HERE.
See Scientific Specialties (SSIbio) All Range HERE
March 25, 2024
The original article was provided by SSIbio (Scientific Specialties).
The IsoFreeze PCR rack plays a crucial role in maintaining the stability of samples during the qPCR process.
Sample Preservation:
Many protocols require the rapid processing of cells at near-physiological conditions to prevent unwanted alterations in gene expression or cell death. Cells are typically kept on ice or on an IsoFreeze PCR rack during collection and storage at -80 °C if not processed immediately. The IsoFreeze PCR rack helps maintain a stable and low-temperature environment, crucial for preserving the integrity of the samples.
Temperature Control:
During various steps of the qPCR protocol, including cell picking, lysis, and reverse transcription, maintaining consistent and appropriate temperatures is essential for the success of the experiment. The IsoFreeze PCR rack helps in achieving this by providing a uniform cooling surface, preventing fluctuations in sample temperature that could adversely affect the results.
Compatibility with High-Throughput Techniques:
The qPCR protocol aims for high-throughput single-cell transcriptome analysis. The IsoFreeze PCR rack is suitable for accommodating multiple tubes or 96-wells plates containing single cells, facilitating efficient processing of a large number of samples simultaneously.
Overall, the IsoFreeze PCR rack contributes to the success of qPCR by providing a stable, low-temperature environment necessary for preserving sample integrity and ensuring reliable results.
Scientific Specialties IsoFreezer PCR Rack is designed for laboratories, research facilities, and scientific settings, offering ideal storage for samples, reagents, and laboratory materials.
Include Scientific Specialties IsoFreezer Racks & Other Racks in Your Lab HERE.
See Scientific Specialties (SSIbio) All Range HERE
March 25, 2024
Interpath Services, as part of the Bunzl group, is stepping up its efforts in tackling climate change and committing to being net zero by 2030.
The roadmap toward this ambitious goal involves a dedicated focus on minimizing emissions from both the fleet (scope 1) and facilities (scope 2) across the Asia Pacific region.
Scott Mayne, Managing Director of Bunzl Asia Pacific, emphasizes the necessity of this commitment, stating, "We are serious about playing our part in reducing emissions across the business. We want to support global efforts to limit warming, minimize biodiversity loss, and help create a net-zero economy by 2030. We believe in creating a sustainable environment for us and for those who follow."
Interpath Services, as a trusted partner to its customers, collaborates closely with leading companies across sectors to achieve sustainability objectives, recognizing the importance of transitioning to sustainable products, packaging, and reducing waste to support a circular economy. The commitment to net zero within a short timeframe underscores Interpath's responsiveness to stakeholder priorities, particularly in addressing climate change concerns.
Felicity Kelly, Head of Sustainability for Bunzl Asia Pacific, highlights that carbon emission reduction has been a central focus, with a significant 3% reduction achieved between 2020-2021 through site consolidation and efficiency improvements.
Ferm Calzado-Munoz, Group Real Estate Manager, shares insights into the ongoing focus on further reducing emissions, including investments in best practice facility design and construction. The initiative of a new Sydney distribution centre, a 6-star GreenStar-rated facility, exemplifies the efficiency gains achievable through thoughtful design.
Looking ahead, Interpath Service aims to install on-site solar panels in key distribution centres by 2023 and is actively transitioning to hybrid vehicles in its passenger fleet. Investments in renewable electricity and credible carbon offsetting programs are also on the agenda to address unavoidable emissions.
As a global entity with operations across more than 30 countries and recognizing the magnitude of climate change, Bunzl APAC is committed to ambitious action. Being part of the "Business Ambition for 1.5 C" campaign and the "Race to Zero" underscores Bunzl APAC's dedication to science-based, net-zero-aligned emissions reduction targets.
Globally, the Bunzl group has set targets for scopes 1 and 2, including a 25% improvement in carbon efficiency by 2025 and 50% by 2030 (against a 2019 baseline). Additionally, there's a commitment to 100% group-wide renewable energy procurement by 2030, with a net-zero target by 2050, encompassing scope 3. Progress is well underway, with a 12% improvement in carbon efficiency and a 60% reduction in carbon intensity since 2010, as highlighted in the 2021 reporting.
Ms. Kelly affirms that Bunzl Asia Pacific's net zero target aligns seamlessly with Bunzl's global commitments. Collaborating with partners on scope 3 emissions through 2050 and working closely with freight providers to close the gap on emissions reflect Interpath's commitment to meeting the 2050 target.
To delve deeper into Interpath's commitment to sustainability and alignment with the Bunzl group's global vision, watch the video 'Sustainability: Tailored Solutions for a Better World.'
March 25, 2024
Interpath Services, driven by purpose, boasts a Sales Team distinguished by its exceptional expertise. In a bid to illuminate the wealth of knowledge within the team, we present a series of insightful interviews.
Today, we engage in a conversation with Rachida Kerrout, a seasoned Account Manager, who graciously shares her wealth of experience and invaluable contributions to Interpath.
Career Background and Suitability:
Rachida's journey spans over a decade in the dynamic life science industry, encompassing diverse roles across various businesses. Armed with a Bachelor's degree in biomedical science, she has not only amassed a wealth of knowledge but also fostered enduring relationships with customers throughout her career journey.
Role and Expertise:
As an Account Manager with a focus on Victoria, specifically Bayside and Southeast territories, Rachida's expertise is centered around liquid handling, microbiology, and cell culture products. Her role involves not only providing solutions but also forging meaningful connections with her clientele.
Enjoyment in Role:
Rachida derives immense satisfaction from the personal touch inherent in her role. The opportunity to be face-to-face with customers, delve into their work, and build on existing relationships is what fuels her passion. Acknowledging the responsibility that comes with her role, she values the trust customers place in her during challenging situations, seeing it as an opportunity to strengthen relationships and contribute to Australia's flourishing life science research landscape.
Initial Impressions at Interpath:
Rachida articulates her positive surprise at the trust vested in the team despite Interpath being part of the larger Bunzl corporation. She expresses excitement about the company's recent growth and looks forward to contributing meaningfully to its ongoing success story.
Market Challenges:
Rachida candidly discusses challenges faced by the market, including increased costs, a weakened AUD dollar, and logistical complications. These challenges necessitate strategic decisions such as price adjustments, impacting customer preferences. She underscores the importance of adapting to changing customer dynamics, as they increasingly prefer self-interaction, making continuous website improvement crucial.
Priorities for 2024:
With a shift back to in-office work, Rachida outlines her priorities for the year. Increased face-to-face visits top the list, recognizing the indispensable value of personal interactions in understanding customer requirements and building stronger relationships. Reflecting on the commendable growth in 2023, her aim is to expand Interpath's presence in sectors like food, beverage, and pharmaceutical production, diversifying beyond the traditionally focused areas of pathology, academia, and research.
Industry Trends of 2024:
Rachida sheds light on prevailing industry trends, noting a significant focus on mRNA research with substantial grants supporting this area. She also highlights the exciting growth in cellular agriculture, an experimental frontier that holds promising potential for the future.
Customer Challenges:
Customers grapple with challenges such as price hikes and inconsistent product supply amid market fluctuations. Rachida emphasizes the need for closer collaboration, offering not just products but also advice and support to navigate these challenges effectively.
Lessons Learned:
Rachida imparts a crucial lesson drawn from the past 12-18 months: it is better to be proactive than reactive. Strengthening communication channels, offering alternatives, and a deepening understanding of customers and products have been instrumental in exceeding expectations.
Message to Customers:
In a heartfelt message to customers, Rachida expresses Interpath's commitment to working closely with them to ensure mutual success. She places high value on customer feedback and assures them of expert support, especially in the Greiner preanalytics division, where the team provides unwavering support during and after purchases.
Rachida Kerrout's journey at Interpath epitomizes dedication, expertise, and a commitment to collaborative success. As we continue to unravel the diverse experiences within Interpath's Sales Team, stay tuned for more in-depth insights from our purpose-driven professionals.
If you would like to contact Rachida or one of the Interpath team, please do so HERE.
February 19, 2024
February 19, 2024
In the dynamic world of life science services, Interpath Services (IPS) shines as a purpose-driven business with a standout Sales Team. What sets IPS apart? It's the wealth of knowledge within their team. Let's kick off our interview series by getting to know Lorenna Salge, Clinical Applications Specialist, who joined over ten years ago.
Crafting Expertise: A Journey into Clinical Pathology
Lorenna Salge, a medical scientist with a knack for Clinical Pathology, brings a rich background to IPS. With eight years in various lab departments pre-IPS, she's now a go-to person for leading suppliers Vacuette and Copan. Lorenna not only knows the products but can make them sing, helping customers optimize their lab operations.
A Role Beyond Transactions: Shaping Pathology Support
Lorenna's role, born last year, isn't just about sales; it's about being there for the entire customer journey. From decision-making to post-sales and troubleshooting, she's like the GPS of pathology support. Her Microbiology and blood collection background fits like a glove, ensuring personalized guidance for customers.
Passion for Project Management: Seamless Integration Matters
What lights Lorenna up? Managing projects with customers. From picking the right products to smooth integration, she believes in giving comprehensive support for seamless workflows. It's not just about selling; it's about making sure the product becomes an essential part of the customer's lab life.
A Decade of Growth: Close Customer Relationships Endure
Lorenna, in her 11 years with IPS, highlights the close relationships with customers as fundamental. Even after joining the Bunzl family, the commitment to top-notch service and tight customer bonds remains unshaken, showcasing the true spirit of IPS.
Navigating Challenges: Retaining Customers Amidst Competition
COVID-19 and increased competition pose challenges, but Lorenna stresses the power of exceptional customer service and clinical know-how. This winning combo, she believes, is the secret sauce for IPS's continued success.
Priorities for 2024: Nationwide Understanding for Nationwide Success
In 2024, Lorenna aims to be a nationwide expert. Her goal is to understand the blood collection and swab collection businesses across all states, ensuring IPS is not just a local hero but a nationwide champ.
Industry Trends of 2024: Automation, Personalized Medicine, Sustainability
What's on Lorenna's radar? Three big trends – Automation and Robotics, Personalized Medicine, and Sustainability. IPS plans to stay ahead by embracing these trends, making sure its offerings align with the ever-evolving market.
Industry Challenges: Shifting Towards Value-Based Care Models
Adapting to value-based care models is a challenge, but Lorenna is up for it. By aligning IPS products with these trends, she aims to contribute to better patient care and outcomes.
Key Lesson Learned: The Power of Effective Communication
Lorenna's big lesson? Communication is key. Whether it's training sessions or presentations, clear and concise communication ensures everyone understands the ins and outs of IPS products.
A Message to Customers: A Smooth Transition to Success
To customers considering a switch, Lorenna assures that change doesn't have to be scary. With IPS, it's about smooth transitions and beneficial processes. From the first chat to ongoing education, IPS is there for every step, ensuring your lab's success.
Lorenna Salge's journey showcases the heart and soul of Interpath Services. Stay tuned for more stories from the incredible team shaping the success of IPS in the competitive world of life science services.
If you would like to contact Lorenna or one of the Interpath team, please do so here.
February 19, 2024
The original article was provided by Greiner Vacuette.
Introduction:
In contemporary medicine, capillary blood collection is gaining popularity as a specimen material due to its simplicity and minimally invasive sampling procedure. This method is particularly beneficial for various patient groups, offering advantages such as reduced blood volumes, quicker test results, and lower risk of complications¹. However, maintaining the quality of capillary blood samples is crucial for obtaining reliable test results.
The Importance of Capillary Blood Collection:
Capillary blood sampling is vital, especially for paediatric patients, individuals with specific health conditions, and those who self-test for parameters like glucose. The success of this method relies on several key steps, including selecting the puncture site, choosing the appropriate lancet, using micro-collection devices, and executing the skin puncture with precision³.
Challenges and Limitations:
Despite its advantages, capillary blood sampling comes with inherent challenges that can lead to inaccurate test results. Factors such as the composition of capillary blood, potential contamination, and differences between venous and capillary blood analyte concentrations should be considered to ensure the reliability of diagnostic outcomes⁴ .
Recommendations for Successful Capillary Blood Collection:
To achieve high-quality capillary blood collection, awareness of potential limitations is crucial. Proper handling techniques, adherence to safety standards, and careful consideration of order of draw and filling are essential steps in minimizing the risk of false test results. Ensuring that workstations are adequately equipped, supplies are within their shelf life, and proper labeling is performed according to required tests and additives are key preparatory measures².
Procedural Steps for Capillary Blood Collection:
- Equip workstations adequately before sampling².
- Follow safety standards and guidelines for blood sampling devices⁴.
- Take necessary precautions, including hand disinfection and patient identification².
- Select and label the appropriate capillary blood tube for the requested tests².
Warm the puncture site if necessary, considering arterialisation for specific analyses³.
- Perform the skin puncture using a retractable incision device³.
- Wipe away the first drop of blood, except when required for specific testing¹.
- Collect capillary blood, following the recommended order of draw for multiple samples¹ ³.
- Cap micro-collection devices immediately to prevent exposure to air⁴.
- Mix capped samples gently to prevent clotting, following manufacturer recommendations¹ ³.
Conclusion: Capillary blood collection is a valuable method in modern medicine, offering advantages for various patient groups. By understanding the challenges associated with this technique and implementing recommended practices, healthcare professionals can ensure high-quality capillary blood samples, leading to accurate and reliable diagnostic outcomes.
[SEE GREINER VACUETTE® MINICOLLECT® CAPILLARY BLOOD COLLECTION SYSTEM]
References:
1 Clinical and Laboratory Standards Institute (CLSI). Procedures and Devices for the Collection of Diagnostic Capillary Blood Specimens; Approved Standard-Sixth Edition, Clinical Laboratory Standards Institute, Wayne, Pennsylvania, USA, 2008.
2 Rat der Europäischen Union. Richtlinie 2010/32/EU des Rates vom 10. Mai 2010 zur Durchführung der von HOSPEEM und EGÖD geschlossenen Rahmenvereinbarung zur Vermeidung von Verletzungen durch scharfe/spitze Instrumente im Krankenhaus- und Gesundheitssektor. Amtsblatt der Europäischen Union. 1. Juni 2010;L 134(53):66–72.
3 Lenicek Krleza J, Dorotic A, Grzunov A, Maradin M. Capillary blood sampling: national recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine. DOI: 10.11613/BM.2015.034, Biochem Med 25(3):335–58.
4 WHO guidelines on drawing blood: best practices in phlebotomy. Gedruckt von WHO Document Production Servis, Genf, Schweiz, 2010. Verfügbar unter: http://www.euro.who.int/__data/assets/pdf_file/0005/268790/WHO-guidelines-on-drawingblood-best-practices-in-phlebotomy-Eng.pdf?ua=1 Abgerufen am 22. Oktober 2016.
February 19, 2024
The original article was provided by Greiner Vacuette.
Pay More Attention to the Risks
At the forefront of our concerns is the need to inform healthcare sector employees about the significant risks they face when handling and disposing of hypodermic needles. Often, these potential hazards go unnoticed or are not taken seriously, leading to a high number of unreported cases of needlestick injuries.
Healthcare professionals engaged in a variety of tasks are particularly exposed to risks when working with sharp and pointed objects like cannulas. Needlestick injuries pose a serious threat, yet their prevalence remains underestimated.
A Serious Consequence
A needlestick injury is not just a health-related concern; it could potentially end a healthcare career. Understanding the gravity of these injuries is crucial for the safety of both healthcare workers and the patients they care for.
Needlestick Injuries Are Far From Trivial
In Europe, approximately one million needlestick injuries occur annually, while In Australia, at least 18,000 healthcare professionals experience a needlestick injury every year. These injuries constitute a significant portion of workplace accidents in the healthcare sector, emphasizing their critical nature due to the potential transmission of bloodborne pathogens.
Which Pathogens are Most Dangerous?
Viruses transmitted via blood, such as Hepatitis B (HBV), Hepatitis C (HCV), and Human Immunodeficiency Virus (HIV), pose the greatest risks. The risk of infection depends on the prevalence of these viruses and the probability of infection.
Danger for Employees in the Healthcare Sector
Needlestick injuries are an occupational hazard for healthcare workers as they can lead to the transmission of bloodborne infections such as human immunodeficiency virus (HIV), hepatitis B and hepatitis C, with the potential for serious complications.
Other infections that can potentially be transmitted via a needlestick injury include malaria, infectious mononucleosis, diphtheria, herpes, tuberculosis and syphilis.
Which Objects Cause Injuries?
Needlestick injuries with hollow needles (injections, blood samples) are more likely to lead to infections than those with surgical needles. The aftermath of an infection can have profound effects on both the career and personal circumstances of the affected person.
How to Protect Yourself
Use of Safety Products
The use of safety products significantly reduces the risk of needlestick injuries. Various technical improvements fall into categories such as active devices requiring activation of the safety mechanism, passive devices that work automatically throughout usage, and others.
A Lot of Needlestick Injuries Could Be Avoided
Studies indicate that the frequency of needlestick injuries can be significantly reduced with the use of safety products. Applying devices with manually activated safety mechanisms, especially those activated while the needle is still in the vein, enhances safety.
How Can I Protect Myself?
The primary safety risk is the lack of education. It is crucial to take risks and warnings seriously, stay informed about potential protection measures, and use safety products. Frequent checks of protection levels are imperative, and adherence to employer-provided safety guidelines is essential.
Avoid Dangerous Working Procedures
For personal protection, avoid dangerous working procedures, use safety products, and dispose of hazardous objects in suitable containers.
Injured! What to Do?
Post-Injury Measures
In case of injury, follow recommended post-injury measures based on WHO guidelines. Recommendations include letting the wound bleed, thorough disinfection, and protection with a sterile bandage. Specific measures depend on the type of injury, such as a prick, cut, contaminated skin, or mucous membrane.
Accident Report is Important
An accident report is crucial for various reasons, including laboratory tests on the affected person and the source of infection, providing certainty and emotional relief. Employers report the incident to the insurance company, ensuring proper documentation and assistance for the affected employee.
Costs
Material and Immaterial Costs
Material costs associated with needlestick injuries are considerable but can be effectively reduced by using safety products. While safety products might have higher acquisition costs, the reduction in injury-related costs over several years offsets this. Immaterial costs, such as worries and concerns of injured employees and their families, cannot be measured in monetary terms.
In conclusion, understanding and implementing safety measures, including the use of safety products, are crucial steps in making needlestick injuries history in the healthcare sector. These practices not only protect healthcare workers but also contribute to substantial economic savings over time.
VACUETTE® QUICKSHIELD Safety Tube Holders & Accessories offer an enhanced safety feature with a manually activated mechanism. This ensures protection even while the needle is still in the vein, providing a higher level of safety.
[FIND GREINER VACUETTE® QUICKSHIELD SAFETY TUBE HOLDERS & ACCESSORIES]
Sign up to get the latest on sales, new releases and more…
Interpath Services is part of Bunzl Australasia, as is Bunzl Australia & New Zealand, Atlas McNeil Healthcare, Bunzl Safety, Fire Rescue Safety Australia (FRSA), Harvey Distributors, Interpath Services, LSH Industrial Solutions Singapore, Medshop, Obex Medical. All are part of the Bunzl plc group of companies.